Business

Director Dealing

Director Dealing.

articleEdx Medical Group PlcMarch 13, 20235/company/edx-medical-group-plc-1/news/director-dealing-260
Director Dealing

About this update from Edx Medical Group Plc

[{"type":"text","content":"\n \n This announcement contains inside information as stipulated under the UK version of the Market Abuse Regulation No 596/2014 which is part of English law by virtue of the European (Withdrawal) Act 2018, as amended.  On publication of this announcement via a regulatory information service, this information is considered to be in the public domain and such persons shall therefore cease to be in possession of inside information.\n LONDON: March 13 March, 2023\n EDX Medical Group Plc\n Director Dealing\n EDX Medical Group plc (“EDX Medical” or the “Company”), which develops innovative digital diagnostic products and services for cancer, heart disease, neurology and infectious disease testing, today announces that Jason Holt, Non-executive Chairman of the Company, purchased 400,000 ordinary shares in the Company at an aggregate price of 3.025 pence per ordinary share on 10 March 2023. Following this purchase, Jason Holt owns 4,400,000 ordinary shares, representing 1.74% of the issued share capital.\n The directors of the Company accept responsibility for the contents of this announcement.\n For more information, please contact:\n EDX Medical PLC\n Mike Hudson\n Tel: 07812345301\n Peterhouse:\n Guy Miller\n Tel: 020 7220 9795\n Media House International,\n Ramsay Smith\n Tel:  +44 (0) 7788 414856:\n \n email:\n \n [email protected]\n \n \n Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.\n \n \n \n 1\n \n \n Details of the person discharging managerial responsibilities / person closely associated\n \n \n \n a)\n Name\n Jason Holt\n \n \n \n 2\n \n \n Reason for the notification\n \n \n \n a)\n Position/status\n Non-executive Chairman\n \n \n b)\n Initial notification /Amendment\n Initial notification\n \n \n \n 3\n \n \n Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor\n \n \n \n a)\n Name\n   EDX Medical Group Plc\n \n \n b)\n LEI\n \n \n \n 213800BZVJZTMCZ6DJ63\n \n \n \n \n \n \n 4\n \n \n Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted\n \n \n \n a)\n Description of the financial instrument, type of instrumen...

More updates from Edx Medical Group Plc